Andrew Combs
Corporate Officer/Principal at PRELUDE THERAPEUTICS INCORPORATED
Net worth: - $ as of 2024-04-29
Andrew Combs active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 2019-03-31 | - |
Career history of Andrew Combs
Former positions of Andrew Combs
| Companies | Position | Start | End |
|---|---|---|---|
| INCYTE CORPORATION | Director of Finance/CFO | 2002-12-31 | 2014-12-31 |
| Corporate Officer/Principal | 2014-12-31 | 2019-01-31 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2001-12-31 | 2002-12-31 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Corporate Officer/Principal | 1996-03-31 | 2002-07-31 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | 1996-03-31 | 2002-07-31 |
Training of Andrew Combs
| University of Wisconsin | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistics
International
| United States | 8 |
Operational
| Corporate Officer/Principal | 5 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| INCYTE CORPORATION | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Andrew Combs
- Experience